Joseph M. Desimone, PhD

Dr. Joseph DeSimone, PhD, is the Chancellor’s Eminent Professor of Chemistry at the University of North Carolina at Chapel Hill, and the William R. Kenan Jr. Professor of Chemical Engineering at NC State University and of Chemistry at UNC. He is an adjunct member of the Cancer Nanocenter at the Memorial Sloan-Kettering Cancer Center. He has published over 300 scientific articles and has over 200 issued and pending patents. Dr. DeSimone is one of only a few individuals elected to all 3 branches of the US National Academies: the National Academy of Medicine, the National Academy of Sciences, and the National Academy of Engineering. He is also a member of the American Academy of Arts and Sciences. Dr. DeSimone has received over 50 major awards and recognitions including the 2015 Kabiller Prize in Nanoscience and Nanomedicine, the 2015 Dickson Prize from Carnegie Mellon University, the 2014 Industrial Research Institute Medal, the 2014 Kathryn C. Hach Award for Entrepreneurial Success from the ACS, 2013 Fellow of the National Academy of Inventors, the 2012 Walston Chubb Award for Innovation presented by Sigma Xi, the 2010 AAAS Mentor Award, the 2009 NIH Director’s Pioneer Award, the 2009 North Carolina Award (the highest honor the State of North Carolina can bestow), the 2008 Lemelson-MIT Prize for Invention and Innovation, the 2008 Tar Heel of the Year by the Raleigh News & Observer, the 2007 Collaboration Success Award from the Council for Chemical Research, the 2005 ACS Award for Creative Invention, the 2002 John Scott Award presented by the City Trusts, Philadelphia (given to “the most deserving” people whose inventions have made outstanding contributions to the “comfort, welfare and happiness” of mankind), the 2002 Engineering Excellence Award by DuPont, the 2002 Wallace H. Carothers Award from the Delaware Section of the ACS, and the 2000 Oliver Max Gardner Award from the University of North Carolina (given by the Board of Governors’ Committee to the person who “has made the greatest contribution to the welfare of the human race”). In 2002 DeSimone, along with Dr. Richard Stack (Duke University) and Dr. Robert Langer (MIT), co-founded Bioabsorbable Vascular Solutions (BVS) to commercialize a fully bioabsorbable, drug-eluting stent that is now used worldwide. Dr. DeSimone’s research is focused on harnessing semiconductor industry fabrication technologies to design high-performance, cost-effective vaccines and medicines. He and his team developed a fabrication technology called PRINT (Particle Replication in Non- wetting Templates) in 2004, forming a foundation for the Carolina Center for Cancer Nanotechnology Excellence funded by the National Cancer Institute. In 2004 Dr. DeSimone launched Liquidia Technologies, which has brought its first product, a seasonal influenza vaccine based on PRINT particles, into clinical trials. Dr. DeSimone received his BS in chemistry from Ursinus College and his PhD in chemistry from Virginia Tech. Dr. DeSimone is currently on leave from the university to be the CEO of Carbon3D after co-founding the company based on a recent breakthrough in 3D printing called Continuous Liquid Interface Production (CLIP).

  • Chancellor’s Eminent Professor of Chemistry, University of North Carolina at Chapel Hill
  • William R. Kenan Jr. Professor, Department of Chemical Engineering, North Carolina State University
  • Professor, Department of Chemistry, University of North Carolina
  • Adjunct Member, Memorial Sloan-Kettering Cancer Center’s Cancer Nanocenter
  • CEO & Co-Founder, Carbon3D